DOUGLAS FAMBROUGH - 10 Dec 2021 Form 4 Insider Report for Dicerna Pharmaceuticals Inc (DRNA)

Role
Chief Executive Officer, Director
Signature
/s/ Douglas W. Pagan, attorney-in-fact
Issuer symbol
DRNA
Transactions as of
10 Dec 2021
Transactions value $
$599,987
Form type
4
Filing time
13 Dec 2021, 18:33:46 UTC
Previous filing
10 Aug 2021
Next filing
17 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRNA Common Stock Options Exercise $100K +33.7K +78% $2.97* 76.8K 10 Dec 2021 Direct
transaction DRNA Common Stock Options Exercise $500K +146K +190.27% $3.42* 223K 10 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRNA Employee Stock Option (Right to Buy) Options Exercise $0 -33.7K -14.96% $0.00 191K 10 Dec 2021 Common Stock 33.7K $2.97 Direct F1
transaction DRNA Employee Stock Option (Right to Buy) Options Exercise $0 -146K -72.64% $0.00 55.1K 10 Dec 2021 Common Stock 146K $3.42 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As of the transaction date, the option was fully vested. The option vested in 48 monthly installments over the four-year period starting on the last day of January 2017.
F2 As of the transaction date, the option was fully vested. The option vested 1/48 monthly on last day of each month with a vesting start date of 07/30/2013.